A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma.

Trial Profile

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Cyclophosphamide; Denileukin diftitox; Doxorubicin; Prednisone; Vincristine
  • Indications Peripheral T-cell lymphoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 15 Nov 2013 Planned end date changed from 1 Jan 2015 to 1 Nov 2014 as reported by ClinicalTrials.gov.
    • 16 Sep 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 23 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top